Print this page

Members of the Executive Board of Merck KGaA 

Notes on memberships of statutory supervisory boards and comparable German and foreign supervisory bodies (section 285 No. 10 HGB in conjunction with section 125 (1) sentence 5 AktG)

XLS

 

 

 

 

Memberships of

Member

(a)
(b)

statutory supervisory boards and
comparable German and foreign supervisory bodies
of corporations

1

Pursuant to the Commercial Registry entry dated August 20, 2012, Bertelsmann AG was transformed into Bertelsmann SE & Co. KGaA on August 20, 2012 by means of a change in legal form

Karl-Ludwig Kley
Darmstadt
Chairman

(a)



– Bertelsmann AG/Bertelsmann SE & Co. KGaA1, Gütersloh
– Bertelsmann Management SE, Gütersloh (since May 4, 2012)
– BMW AG, Munich (Vice Chairman)
– 1. FC Köln GmbH & Co. KGaA, Cologne (Chairman)

Kai Beckmann
Griesheim, Head of Group Human Resources

no board positions

Stefan Oschmann
Munich, Responsible for the Merck Serono
and Consumer Health divisions

(b)


– Merck Serono S.A.,Coinsins, Switzerland
   (Chairman) (until April 18, 2012)

Bernd Reckmann
Seeheim-Jugenheim, Responsible for the Performance Materials and Merck Millipore divisions

no board positions

Matthias Zachert
Bonn, Chief Financial Officer

no board positions

The general partners with no equity interest (Executive Board) manage the business activities in accordance with the laws, the Articles of Association and the rules of procedure. They are appointed by E. Merck KG with the consent of a simple majority of the other general partners. The members of the Executive Board are jointly responsible for the entire management of the company. Certain tasks are assigned to individual Executive Board members based on a responsibility distribution plan. Each Executive Board member promptly informs the other members of any important actions or operations in his respective business area. The Executive Board is responsible for preparing the annual financial statements of Merck KGaA and of the Group as well as for approving the quarterly and half-year financial statements of the Merck Group. In addition, the Executive Board ensures that all legal provisions, official regulations and the company’s internal policies are abided by, and works to achieve compliance with them by all the companies of the Merck Group. A Group-wide guideline defines in detail which transactions require prior Executive Board approval.

The Executive Board provides the Supervisory Board with regular, up-to-date and comprehensive reports about all company-relevant issues concerning strategy, planning, business developments, the risk situation, risk management and compliance. The rules of procedure of the Executive Board and of the Supervisory Board as well as a Supervisory Board resolution regulate further details on the information and reporting duties of the Executive Board vis-à-vis the Supervisory Board.

The Executive Board informs the Board of Partners and the Supervisory Board at least quarterly of the progress of business and the situation of the company. In addition, the Executive Board informs the stated boards at least annually of the company’s annual plans and strategic considerations.

The Executive Board passes its resolutions in meetings that are normally held twice a month.

© Merck KGaA, Darmstadt, Germany, Last Update 2013/03/07